Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update.
Saved in:
| Title: | Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update. |
|---|---|
| Authors: | Patel PJ; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK., Devonport H; The Ophthalmology Department, Bradford Royal Infirmary, Bradford, UK., Sivaprasad S; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK., Ross AH; The Ophthalmology Department, Bristol Eye Hospital, Bristol, UK., Walters G; Department of Ophthalmology, Harrogate District Hospital, Harrogate, UK., Gale RP; The Ophthalmology Department, The York Hospital and Department of Health Sciences, University of York, York, UK., Lotery AJ; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Mahmood S; Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Talks JS; Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Napier J; Medical Affairs, Bayer plc, Reading, Berkshire, UK. |
| Source: | Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2017 Nov 06; Vol. 11, pp. 1957-1966. Date of Electronic Publication: 2017 Nov 06 (Print Publication: 2017). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101321512 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5467 (Print) Linking ISSN: 11775467 NLM ISO Abbreviation: Clin Ophthalmol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
